Toro Energy Ltd (ASX:TOE) Announces Updated Scoping Study
Toro Energy (ASX:TOE) updates Lake Maitland Scoping Study with a pre-tax NPV of A$907.9M and a 56% IRR.
Toro Energy (ASX:TOE) updates Lake Maitland Scoping Study with a pre-tax NPV of A$907.9M and a 56% IRR.
Avecho Biotechnology Limited (ASX:AVE) receives $1.66M under the R&D Tax Incentive to support its Phase III insomnia trial and commercialization efforts.
CAQ Holdings Limited (ASX:CAQ) restructures existing debt and secures a RMB6 million loan to support operational activities.
Talius Group Limited (ASX:TAL) will consolidate its Ordinary Shares on a 10-for-1 basis following shareholder approval, aiming to streamline its capital structure.
A three-year partnership with AFL Barwon aims to expand HITIQ’s PROTEQT concussion management technology to over 25,000 players in regional Victoria.
Goodman Group (ASX:GMG) reports Q3 FY25 operational progress with $13.7bn WIP and reaffirms 9% EPS growth forecast.
Neuren Pharmaceuticals (ASX:NEU) reports a record A$166m income in 2024, driven by DAYBUE sales and initiates Phase 3 trials for NNZ-2591.
Imugene Limited (ASX:IMU) announces an Extraordinary General Meeting to discuss share consolidation and the issuance of new shares to support its clinical projects.
Assetora Limited (ASX:AOH) launches the Australian Homeowner Equity Fund, providing a unique shared equity solution for investors and homeowners.
DXN Limited (ASX:DXN) secures a A$2 million contract with DP World Australia to deliver modular data centres in New South Wales.